Roivant Sciences (ROIV) Long-Term Investments (2021 - 2025)

Roivant Sciences (ROIV) has 4 years of Long-Term Investments data on file, last reported at $163.0 million in Q4 2024.

• Quarterly Long-Term Investments rose 19.92% year-over-year to $163.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $163.0 million (up 19.92% YoY) and the FY2024 annual result came in at $163.0 million, up 19.92% from the prior year.
• Long-Term Investments advanced to $163.0 million in Q4 2024, from $161.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $220.0 million in Q3 2021 to a low of $100.6 million in Q2 2021.
• A 4-year average of $165.8 million and a median of $163.0 million in 2024 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 19.92% in 2024, down 17.39% in 2024.
• Tracing ROIV's Long-Term Investments over 4 years: stood at $215.7 million in 2021, then dropped by 10.07% to $194.0 million in 2022, then decreased by 29.92% to $135.9 million in 2023, then rose by 19.92% to $163.0 million in 2024.
• The last three Long-Term Investments figures came in at $163.0 million (Q4 2024), $161.8 million (Q3 2024), and $142.9 million (Q2 2024), per Business Quant data.